We are live on ! Find out more
EYEGW

Eyegate Pharmaceuticals, Inc. Warrants
EYEGW

Delisted

EYEGW was delisted on the 5th of August, 2020.

Back to rankings

0 hedge funds and large institutions have $0 invested in Eyegate Pharmaceuticals, Inc. Warrants in 2020 Q3 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 3 → 0 (-3)

100% less capital invested

Capital invested by funds: $8K → $0 (-$8K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 3

Holders
–
Holders Change
-3
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
AIC
AWM Investment Company
New York
-$6K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$2K
Name Holding Trade Value Shares
Change 		Change in
Stake
AIC
1
AWM Investment Company
New York
– -$6K -137,092 Closed
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
– -$2K -35,621 Closed

EYEGW Hedge Fund Activity: Q3 2020 in Review

0 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Eyegate Pharmaceuticals, Inc. Warrants (EYEGW) for Q3 2020, worth a combined $0 — down 100% from $8K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of EYEGW and 0 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was AWM Investment Company, exiting entirely with an estimated $6K sold.

  • 0 institutional investors held Eyegate Pharmaceuticals, Inc. Warrants (EYEGW) as of Q3 2020, down from 3 in Q2 2020.
  • Funds reported $0 of Eyegate Pharmaceuticals, Inc. Warrants stock for Q3 2020, down 100% quarter-over-quarter.
  • 0 funds opened new Eyegate Pharmaceuticals, Inc. Warrants positions in Q3 2020 and 3 closed out, a net change of -3 holders.
  • The largest Eyegate Pharmaceuticals, Inc. Warrants seller in Q3 2020 was AWM Investment Company, an estimated $6K sold.

Based on aggregated 13F filings for Q3 2020.